METOCARD T 25 Tablet 15's

15 Tablet(s) in a Strip Mkt: Torrent Pharmaceuticals Ltd Country of Origin: India
Hypertension Rx required
MRP ₹312.00
Inclusive of all taxes
Get this at ₹255.84
Cart Total
₹0
METOCARD T 25 Tablet 15's ₹255.84
MRP ₹312.00
Medicine requires valid prescription GOT IT
Request and get upto 20% OFF on high priced medicines. Request Now

Expiry on or after

Pincode

Happy Customers 9M+ Happy Customers
Authentic Products 100% Authentic
Best Quality Quality Checked Products
Showing 56 substitutes for METOCARD T 25 Tablet 15's
ALTERNATE BRANDS
Metosartan 25mg Tablet 10'S
Prescription Hypertension Rx required
MRP ₹ 173.00
Get this at ₹ 138.40 >
Tazloc Beta 25mg Tablet 10'S
Prescription Hypertension Rx required
MRP ₹ 170.30
Get this at ₹ 136.24 >
Telmikind Beta 25mg Tablet 10'S
Prescription Hypertension Rx required
MRP ₹ 109.90
Get this at ₹ 87.92 >
Show more

Introduction About METOCARD T 25 TABLET

METOCARD T 25 TABLET is a fixed-dose combination that combines Metoprolol and Telmisartan. It is commonly advised in cases where individuals are managing their blood pressure levels under clinical supervision. This dual-action formulation supports heart health and vascular function.

METOCARD T 25 TABLET is a combination of Beta-blocker and Angiotensin Receptor Blocker (ARB). Usually used under clinical guidance for cardiovascular wellness. Each tablet contains Metoprolol Succinate 25mg and Telmisartan 40mg. It is a convenient once-daily dosage (as directed by your healthcare provider).

Always follow the dosage recommended by your healthcare expert. Typically advised to be taken with or without food, preferably at the same time each day. Swallow whole with water.

The most common side effects of taking METOCARD T 25 TABLET are dizziness or tiredness. Consult your doctor if any of the side effects persist.

Store METOCARD T 25 TABLET below 30°C in a dry place, away from sunlight. Keep out of reach of children. Do not discontinue without consulting a healthcare provider.

Key Composition

1. Metoprolol Succinate (25 mg)

  • Class: Beta-1 selective beta-blocker
  • Function: Helps manage elevated blood pressure and reduces the strain on the heart by slowing the heart rate and decreasing cardiac output

2. Telmisartan (Unspecified strength in 25mg variant, often 40 mg)

  • Class: Angiotensin II Receptor Blocker (ARB)
  • Function: Relaxes blood vessels by blocking angiotensin II receptors, making it easier for blood to flow

Uses Of METOCARD T 25 TABLET

  • Used to manage high blood pressure (Hypertension)

Key highlights of METOCARD T 25 TABLET:

  • Combination of Beta-blocker and Angiotensin Receptor Blocker (ARB)
  • Used under clinical guidance for cardiovascular wellness
  • Each tablet contains Metoprolol Succinate 25mg + Telmisartan 40mg
  • Convenient once-daily dosage (as directed by your healthcare provider)

Benefits of METOCARD T 25 TABLET

1. Supports blood pressure management

  • METOCARD T 25 TABLET combines two active ingredients which work together to help support blood pressure control when used regularly under medical supervision

2. Reduces daily pill burden

  • Instead of taking two separate medicines, this combination tablet simplifies your routine, which can encourage better medication consistency over time

3. Helps the heart work more efficiently

  • By easing strain on the heart and allowing smoother blood flow,METOCARD T 25 TABLET supports cardiovascular health as part of a medically supervised routine

4. Convenient once-daily use

  • Designed to be taken once a day, it fits easily into your daily schedule, ideal for people with busy lifestyles

5. Suitable for long-term use as directed

  • This tablet is commonly prescribed as part of a long-term care plan. Its dual-action approach may support overall health management goals

6. Patient-Friendly Formulation

  • Formulated to help manage multiple health parameters through a single tablet, making it easier to follow your doctor's plan

How METOCARD T 25 TABLET Works

How does METOCARD T 25 TABLET work in blood pressure control

1. Metoprolol Succinate (25 mg) - A Beta-1 Selective Blocker:

  • Role: Helps manage the heart rate and reduces the force of heart contractions
  • Impact: This may support reduced workload on the heart and promote more efficient circulation throughout the body

2. Telmisartan – An Angiotensin II Receptor Blocker (ARB):

  • Role: Helps relax and widen the blood vessels by blocking certain natural chemicals in the body
  • Impact: When blood vessels stay relaxed, blood can flow more easily, aiding in blood pressure management

3. Dual-Action Mechanism:

This dual approach supports blood pressure regulation by:

  • Managing heart activity through Metoprolol
  • Relaxing blood vessels through Telmisartan

How to use METOCARD T 25 TABLET

  • Always follow the dosage recommended by your healthcare expert
  • Typically advised to be taken with or without food, preferably at the same time each day, Swallow whole with water
  • Do not crush, chew, or break the tablet unless advised by a doctor

How to take METOCARD T 25 TABLET safely?

  • Take the tablet once daily, preferably at the same time each day to maintain consistency
  • Do not adjust the dose on your own, always consult your doctor before making changes

Can METOCARD T 25 TABLET be taken on an empty stomach?

  • Yes, METOCARD T 25 TABLET can usually be taken with or without food, unless your doctor advises otherwise
  • Taking it with food may help if you experience mild stomach discomfort

What if I forgot to take METOCARD T 25 TABLET

  • If you miss a dose take it as soon as you remember
  • If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule
  • Do not take a double dose to make up for the missed one, as this may increase the risk of side effects

Overdose

  • Symptoms of overdose include severe dizziness, excessive drop in blood pressure, low or irregular heartbeat and breathing difficulties
  • In case of an overdose, seek immediate medical attention or call a poison control center

Side Effects Of METOCARD T 25 TABLET

Common side effects:

  • dizziness
  • tiredness

When to consult your doctor?

  • Sepsis (a life-threatening severe infection occurring due to damage of whole-body immune response)
  • Angioedema (rapid and serious swelling of the skin and mucosa)

How To Manage Side Effects

Dizziness Or Drowsiness

  • Sit or Lie Down: If you feel dizzy, sit down or lie down immediately to prevent falling. Keep your head still and close your eyes if needed
  • Hydrate: Dehydration can cause dizziness, so drink water or electrolyte-replenishing drinks like sports drinks
  • Avoid Sudden Movements: When standing or sitting, do so slowly to avoid triggering dizziness. Take your time when getting up

Tiredness

  • Drinking enough water throughout the day helps support circulation and energy levels
  • Aim for 7–8 hours of restful sleep each night
  • Mild exercises like walking, stretching, or yoga can boost natural energy
  • If tiredness persists or affects your daily routine, speak to your healthcare provider

Warning & Precautions

Pregnancy

Contraindicated

Human and animal studies have indicated that the use of telmisartan (one of the components in this medicine) has shown to cause fetal harm. Therefore, METOCARD T 25 TABLET is not recommended for use in pregnant women. If you are pregnant or think you may be pregnant consult your doctor for advice.

Breastfeeding

Contraindicated

METOCARD T 25 TABLET is not recommended for use in breastfeeding women. Animal studies suggest that Telmisartan is excreted in breast milk and can lead to potential adverse effects on the lactating neonate. Therefore, consult your doctor before taking this medicine.

Driving and Using Machines

Use with Caution

Do not drive or operate machines if you feel dizzy or tired after taking METOCARD T 25 TABLET.

Alcohol

Consult your doctor

Avoid consumption of alcohol while taking METOCARD T 25 TABLET since it may aggravate the low blood pressure.

Kidney

Consult your doctor

METOCARD T 25 TABLET is not recommended for use if have impaired kidney function and managed with a blood pressure lowering medicine containing aliskiren. It should be used with caution if you have certain kidney disease such as renal artery stenosis (narrowing of the blood vessels to one or both kidneys) or have undergone kidney transplant.

Liver

Consult your doctor

METOCARD T 25 TABLET is not recommended for use in patients with severe liver problems such as cholestasis or biliary obstruction (disease causing difficulty in drainage of the bile from the liver and gall bladder). It should be used with caution in patients with liver diseases such as hepatic impairment.

Allergy

Contraindicated

METOCARD T 25 TABLET is not recommended for use if you are allergic to metoprolol, telmisartan or any other ingredients of this medicine.

Lungs

Use with Caution

METOCARD T 25 TABLET should be used with caution in patients bronchospastic disease (disease causing tightening of airway muscles) such as asthma, emphysema, chronic obstructive pulmonary disease or lung infections.

Heart Disease

Consult your doctor

METOCARD T 25 TABLET is not recommended for use in patients with heart disease such as severe bradycardia (low heart rate), heart block greater than first degree, cardiogenic shock, decompensated cardiac failure or sick sinus syndrome. It should be used with caution in patients having heart trouble.

Use In Pediatrics

Contraindicated

METOCARD T 25 TABLET is not recommended for use in children and adolescents (aged below 18 years). Animal studies in young rats have shown that high doses may affect kidney development and function. These studies indicated potential adverse effects, including reduced renal perfusion and delayed renal maturation.

Use In Geriatrics

Use with Caution

METOCARD T 25 TABLET should be used with caution in elderly patients (aged 65 years and above). Regular monitoring of renal and liver function tests is advised.

Other Warnings for METOCARD T 25 TABLET

Before taking METOCARD T 25 TABLET, inform your doctor if you:

  • have pheochromocytoma
  • have diabetes or hypoglycaemia
  • have history of anaphylactic reactions
  • have thyrotoxicosis
  • have peripheral vascular disease
  • raised aldosterone levels
  • low blood pressure due to dehydration
  • have deficiency of salt due to diuretic therapy (water tablets), low-salt diet, diarrhoea or vomiting
  • have elevated potassium levels in the blood

Who should not take [GBNKEYWORD

METOCARD T 25 TABLET is not recommended for use if you:

  • Are planned for non-cardiac surgery

Safety Advice

  • Always take METOCARD T 25 TABLET exactly as advised by your doctor to effectively manage hypertension
  • Regularly check your blood pressure at home to ensure the medication is working effectively
  • Do not stop taking METOCARD T 25 TABLET abruptly, as it may cause a sudden rise in blood pressure or other complications
  • Drink plenty of fluids, especially in hot weather, to prevent dehydration, which can lower blood pressure excessively
  • Limit salt intake and follow a balanced, heart-healthy diet for optimal results. Avoid potassium-rich foods (e.g., bananas, oranges) unless advised otherwise, as Telmisartan may increase potassium levels
  • Avoid alcohol consumption while on this medication, as it can increase drowsiness and dizziness
  • Avoid Driving or Heavy Machinery: it may cause dizziness or fatigue, especially when starting the treatment. Avoid tasks requiring alertness until you know how it affects you
  • Not recommended for use during pregnancy or breastfeeding. Consult your doctor immediately if you become pregnant while taking this medication
  • Seek immediate medical attention if you accidentally take more than the prescribed dose, as it may cause severe dizziness, fainting, or a slow heartbeat
  • Start with a lower dose if prescribed for elderly patients, as they are more susceptible to side effects like hypotension and dizziness
  • Visit your doctor for regular blood tests to monitor potassium levels, kidney function, and overall response to the medication

Drug - Drug interaction

1. Interactions with Antihypertensive Medications

  • Other RAAS Inhibitors (e.g., ACE inhibitors or ARBs): Co-administration can increase the risk of hyperkalemia, kidney dysfunction, or hypotension. Regular monitoring of potassium levels and renal function is recommended
  • Diuretics (e.g., Furosemide, Hydrochlorothiazide): Co-administration may lead to an excessive drop in blood pressure, especially after the first dose, due to synergistic antihypertensive effects

2. Interactions with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

  • Drugs like Ibuprofen, Naproxen, or Aspirin can reduce the antihypertensive effect of this tablet
  • Long-term use of NSAIDs with Telmisartan can impair renal function and increase the risk of renal failure, particularly in elderly patients or those with existing kidney disease.

3. Interactions with Antidiabetic Medications

  • Telmisartan may enhance the blood sugar-lowering effects of insulin or oral antidiabetic drugs, increasing the risk of hypoglycemia.
  • Metoprolol can mask symptoms of hypoglycemia, such as tachycardia, which may delay treatment in diabetic patients

4. Interactions with Drugs Affecting Potassium Levels

  • Potassium-Sparing Diuretics (e.g., Spironolactone, Amiloride) or Potassium Supplements:
  • Telmisartan may increase potassium levels, leading to hyperkalemia, a condition characterized by muscle weakness, fatigue, and irregular heart rhythms.

5. Interactions with Calcium Channel Blockers

  • Amlodipine or other calcium channel blockers combined with Metoprolol may result in an additive effect, leading to severe bradycardia, hypotension, or dizziness.

6. Interactions with Antiarrhythmic Drugs

  • Amiodarone or Digoxin: Metoprolol’s beta-blocking properties may increase the risk of severe bradycardia or conduction disturbances. Digoxin levels should be monitored, as they may rise due to Telmisartan.

7. Interactions with CNS Depressants

  • Sedatives, antidepressants (e.g., SSRIs), or antipsychotics: Metoprolol may amplify the sedative effects of these drugs, causing excessive drowsiness, fatigue, or dizziness.

8. Interactions with Lipid-Lowering Medications

  • Statins (e.g., Atorvastatin, Rosuvastatin): Metoprolol metabolism may be affected, increasing the risk of muscle pain or rhabdomyolysis.

Synopsis

Drug :   Metoprolol, Telmisartan
Pharmacological Category :   Beta-blockers, Angiotensin II receptor antagonists
Therapeutic Indication :   Hypertension (high blood pressure)      
Dosage Forms :   Tablet

 

More Information

Expert insights:

  • Studies suggest that the combination of beta-blockers with ARBs may offer complementary benefits for cardiovascular wellness. A healthcare provider may recommend METOCARD T 25 TABLET when monotherapy does not yield optimal results
  • Always rely on personalized consultation before making decisions
  • METOCARD T 25 TABLET is available at licensed online pharmacies with valid prescription verification protocols.

FAQs About METOCARD T 25 TABLET

Q: What is METOCARD T 25 TABLET used for?

A: METOCARD T 25 TABLET is a fixed-dose combination that combines Metoprolol and Telmisartan. It is commonly advised in cases where individuals are managing their blood pressure levels under clinical supervision. This dual-action formulation supports heart health and vascular function.

Q: What does METOCARD T 25 TABLET contain?

A: Each tablet contains Metoprolol Succinate 25mg and Telmisartan 40mg, working together to support vascular and heart function.

Q: Is METOCARD T 25 TABLET safe for long-term use?

A: METOCARD T 25 TABLET is generally considered suitable for long-term use when taken exactly as prescribed by your healthcare provider. It combines two clinically studied ingredients Metoprolol Succinate and Telmisartan which are often used as part of a long-term approach to support blood pressure and cardiovascular health

Q: Can I take METOCARD T 25 TABLET daily?

A: It is commonly advised once a day under the supervision of a licensed practitioner. Maintain consistency for best outcomes.

Q: Who might be advised METOCARD T 25 TABLET?

A: METOCARD T 25 TABLET is typically recommended by healthcare providers to individuals who may benefit from the combined support of two active ingredients Metoprolol Succinate (25 mg) and Telmisartan in managing blood pressure and maintaining cardiovascular balance

Q: When is the best time to take METOCARD T 25 TABLET?

A: For most people, METOCARD T 25 TABLET is taken once daily, ideally at the same time every day to help maintain consistent effects throughout the day.

Q: Does METOCARD T 25 TABLET cause dizziness?

A: Some people taking METOCARD T 25 TABLET may experience dizziness, especially when starting the medication or after a dosage change. This can happen as the medicine works to support blood pressure and heart function.

Q: How METOCARD T 25 TABLET helps support heart health?

A: METOCARD T 25 TABLET combines two active ingredients Metoprolol Succinate and Telmisartan which work together to support heart health through complementary actions.

Q: What happens if you take more METOCARD T 25 TABLET than your required dose?

A: If you or anyone else accidentally takes too much of METOCARD T 25 TABLET, consult your doctor immediately or visit the nearby hospital. Symptoms of overdose are low blood pressure, fast or slow heartbeat, dizziness, heart block, heart failure, bronchospasm (constriction of lung muscles), hypoxia (lack of oxygen supply to body cells), higher levels of creatinine in the blood, sudden kidney failure, impairment of consciousness or nausea, vomiting.

Q: What side effects are seen with METOCARD T 25 TABLET?

A: The common side effects associated with the use of METOCARD T 25 TABLET are low blood pressure, tiredness, dizziness, depression, diarrhoea, shortness of breath, slow heartbeat and rash. Consult your doctor if any of the side effect worsens.

Q: Who should avoid taking METOCARD T 25 TABLET?

A: METOCARD T 25 TABLET is not recommended for use if you are having asthma, emphysema, chronic obstructive pulmonary disease, lung infections, cholestasis or biliary obstruction, impaired kidney function, severely low heart rate, heart block, cardiogenic shock, decompensated cardiac failure or sick sinus syndrome. It is also not recommended for use in pregnant and breastfeeding women, children and adolescents (aged below18 years).

Q: Is METOCARD T 25 TABLET safe to use in children?

A: METOCARD T 25 TABLET is not recommended for use if you are having asthma, emphysema, chronic obstructive pulmonary disease, lung infections, cholestasis or biliary obstruction, impaired kidney function, severely low heart rate, heart block, cardiogenic shock, decompensated cardiac failure or sick sinus syndrome. It is also not recommended for use in pregnant and breastfeeding women, children and adolescents (aged below18 years).

Q: Can I drink alcohol while taking METOCARD T 25 TABLET?

A: Avoid consumption of alcohol while taking METOCARD T 25 TABLETsince it may aggravate the low blood pressure. However, if you are habitual of drinking alcohol, you must consult your doctor before taking this medicine.

Q: Is METOCARD T 25 TABLET safe to use in patients with kidney problems?

A: METOCARD T 25 TABLET is not recommended for use if have impaired kidney function and managed with a blood pressure lowering medicine containing aliskiren. It should be used with caution if you have certain kidney disease such as renal artery stenosis (narrowing of the blood vessels to one or both kidneys) or have undergone kidney transplant.

References

1. KD. Tripathi. Antihypertensive Drugs. Essentials of medical pharmacology. Seventh edition. 2013. Page-561, 563.

2. Jaekyu Shin, Marco Gonzales, and Mark J Pletcher. Risk of Emergent Bradycardia Associated with Initiation of Immediate- or Slow-Release Metoprolol. NIH National Library of Medicine. National Centre for Biotechnology Information. PubMed Central. June 2013. [Accessed on 13th June 2025] 

3. Accord Healthcare. Electronic Medicine Compendium (EMC). [Revised in July 2021] [Accessed on 13th June 2025] 

4. AstraZeneca AB. Food and Drug Administration (FDA). [Revised in March 2006] [Accessed on 13th June 20252] 

5. Camber Pharmaceuticals, Inc. Metoprolol Succinate Extended-Release Tablets. [Revised in November 2020] [Accessed on 13th June 2025] 

Author Details

Written By Dr. Karthikeyan Rajagopal - M.Pharm (Pharmacology)
Reviewed By Dr. Sankara Babu Gorle - MBBS, MD(Pharmacology) View profile
Last updated on 13 Jun 2025 | 04:49 PM(IST)
    Net Qty
    1 N
    Shelf Life
    720 Days
    Item Weight
    25 g
    Ingredient
    Metoprolol 25 mg+Telmisartan 40 mg
    Hsn Code
    30049079
Disclaimer:

The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.